Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +24.17%
#4 Nockchain Nockchain +18.65%
#5 Velvet Velvet +18.00%
#6 Nillion Nillion +13.02%
#7 FOLKS FOLKS +12.57%
#8 Versatize Coin Versatize Coin +12.49%
#9 Humanity Humanity +11.40%
#10 Bedrock Bedrock +10.87%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Classement en actions #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Prix de l'action
$0.00060315
Dernière synchronisation: 2024-09-27
Capitalisation boursière
$1.65M
Changement (1 jour)
19.64%
Changement (1 an)
0.00%
Pays
SE
Échange Amniotics AB (publ) (AMNI)

Catégorie

Healthcare
Bénéfices pour Amniotics AB (publ) (AMNI)
Bénéfices en Dec 2023 TTM : $-3.09M
Selon les derniers rapports financiers de Amniotics AB (publ), les bénéfices actuels de l'entreprise sont de $-3.09M. En 2022, l'entreprise a réalisé un bénéfice de $-4.61M, une augmentation par rapport à celui de 2021 qui était de $-5.92M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Amniotics AB (publ) de 2018 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE